Evidence map›Paper›PMID 29844694›Full record

ReviewJournal of inflammation research2018

A review of vagus nerve stimulation as a therapeutic intervention.

Rhaya L Johnson, Christopher G Wilson

6 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Journal of inflammation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 270 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
270citing papers in PubMed, 8 pooled it
21.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03869008 naterminatednot on this mapstarted 2019, after this paper: background citation

Potential Benefit for Non Invasive Vagus Nerve Stimulation (nVNS) Using GammaCore in the Treatment of Raynaud's Phenomena.

TypeinterventionalSponsorUniversity of Toledo Health Science CampusRan2019 to 2020Enrolled6ConditionsRaynaud Phenomenon, Primary Raynaud Phenomenon, Raynaud Disease, Raynaud SyndromeArmsgammaCore Sapphire, Sham Device
NCT04514627 nacompletednot on this mapstarted 2020, after this paper: background citation

Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19

TypeinterventionalSponsorOlive View-UCLA Education & Research InstituteRan2020 to 2022Enrolled55ConditionsCOVID-19ArmsAuricular percutaneous neurostimulation
NCT05343039 nacompletednot on this mapstarted 2022, after this paper: background citation

Leveraging Biomarkers and New Technologies to Reduce Self-Injury and Substance Abuse Risk Among Highly Vulnerable Adolescents

TypeinterventionalSponsorUniversity of Notre DameRan2022 to 2025Enrolled30ConditionsNonsuicidal Self Injury, Alcohol Abuse, Vagus Nerve StimulationArmsNon-invasive Transcutaneous Nerve Stimulation (tVNS), No Intervention
NCT05694663 recruitingnot on this mapstarted 2024, after this paper: background citation

Vagal Nerve Stimulation in Enhanced Stroke Recovery: The VALOR Registry

Typeobservational_patient_registrySponsorIcahn School of Medicine at Mount SinaiRan2024 to 2028Enrolled40ConditionsChronic Ischemic StrokeArmsVivistim
NCT06574971 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

Pre-Post Intervention Study to Investigate the Safety, Feasibility, & Efficacy of the NeurGear ZenBud System for the Treatment of Anxiety & Anxiety-Related Symptoms

TypeinterventionalSponsorNeurGearRan2024 to 2025Enrolled30ConditionsAnxiety DisordersArmsLow intensity focused ultrasound using the NeurGear Zenbud
NCT07283913 narecruitingnot on this mapstarted 2025, after this paper: background citation

UltraSONIC Vagus Nerve Stimulation: Investigation U-VNS Effects on Physiological, Emotional and Cognitive Biomarkers

TypeinterventionalSponsorUniversity of NottinghamRan2025 to 2026Enrolled30ConditionsHealthy ParticipantsArmsUltrasound Vagus Nerve Stimulation (U-VNS)
3 · Its place in the literature

Who cites it

270 citing papers in PubMed, 8 syntheses or guidelines pooled it, 543 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Size Scaling of the Electrochemical Performance of TiSmall (Weinheim an der Bergstrasse, Germany) · 2026
    Article

210 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rhaya L JohnsonLawrence D Longo MD Center for Perinatal Biology, Department of Basic Sciences, Loma Linda University, Loma Linda, CA, USA.
Christopher G WilsonLawrence D Longo MD Center for Perinatal Biology, Department of Basic Sciences, Loma Linda University, Loma Linda, CA, USA.
Loma Linda University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this review, we provide an overview of the US Food and Drug Administration (FDA)-approved clinical uses of vagus nerve stimulation (VNS) as well as information about the ongoing studies and preclinical research to expand the use of VNS to additional applications. VNS is currently FDA approved for therapeutic use in patients aged >12 years with drug-resistant epilepsy and depression. Recent studies of VNS in in vivo systems have shown that it has anti-inflammatory properties which has led to more preclinical research aimed at expanding VNS treatment across a wider range of inflammatory disorders. Although the signaling pathway and mechanism by which VNS affects inflammation remain unknown, VNS has shown promising results in treating chronic inflammatory disorders such as sepsis, lung injury, rheumatoid arthritis (RA), and diabetes. It is also being used to control pain in fibromyalgia and migraines. This new preclinical research shows that VNS bears the promise of being applied to a wider range of therapeutic applications.

Indexed as

autonomic circuitsinflammationpediatricsperipheral nerve stimulationvagus nerve stimulation

Identifiers

PMID29844694
PMCPMC5961632
OpenAlexW2803358728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.